Literature DB >> 12835868

[Remifentanil. An update].

W Wilhelm1, M Wrobel, S Kreuer, R Larsen.   

Abstract

Remifentanil is a 4-anilidopiperidine mu-opioid analgesic which is rapidly metabolized by unspecific blood and tissue esterases. According to its unique pharmacokinetic profile, remifentanil-based anaesthesia combines high-dosage opioid analgesia intraoperatively with a rapid and predictable postoperative awakening. When compared with a standard fentanyl-based technique, the use of remifentanil has changed our present anaesthetic regimens. This includes the anaesthesia induction sequence, the choice and dosage of anaesthetics when used as adjuncts to remifentanil, and even more, the proper planning of postoperative pain management. The present paper was designed to review the current knowledge on remifentanil and all aspects of its use in anaesthesiology. In addition, present data on the use of remifentanil for analgesia and sedation of the critically ill patient are summarized.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835868     DOI: 10.1007/s00101-003-0540-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  15 in total

Review 1.  [Burn trauma--Part 2. Anesthesiological, surgical and intensive care management].

Authors:  G A Giessler; T Mayer; T Trupkovic
Journal:  Anaesthesist       Date:  2009-05       Impact factor: 1.041

Review 2.  [Opioids in anesthesia].

Authors:  C Zöllner; M Schäfer
Journal:  Anaesthesist       Date:  2008-07       Impact factor: 1.041

Review 3.  Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications.

Authors:  Ruben S Vardanyan; Victor J Hruby
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

4.  [Analgesia with remifentanil in spontaneously breathing patients undergoing brief but painful radiological procedures].

Authors:  B Moser; A von Goedecke; A Chemelli; C Keller; W Voelckel; K H Lindner; V Wenzel
Journal:  Anaesthesist       Date:  2005-11       Impact factor: 1.041

5.  [Intracranial haemorrhage. A reason for delayed awakening after general anaesthesia].

Authors:  K Morgenthaler; B Larsen; U Grundmann; M Silomon
Journal:  Anaesthesist       Date:  2005-05       Impact factor: 1.041

Review 6.  [General anesthesia for ambulatory surgery : Clinical pharmacological considerations on the practical approach].

Authors:  S Löser; A Herminghaus; T Hüppe; W Wilhelm
Journal:  Anaesthesist       Date:  2014-11       Impact factor: 1.041

Review 7.  Experience with remifentanil in neonates and infants.

Authors:  Lars Welzing; Bernhard Roth
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 8.  [Remifentanil-based intraoperative anaesthesia and postoperative pain therapy. Is there an optimal treatment strategy?].

Authors:  C Zöllner; M Schäfer
Journal:  Anaesthesist       Date:  2007-10       Impact factor: 1.041

9.  [Propofol administration systems. Handling, hemodynamics and propofol consumption].

Authors:  J G Triem; K D Röhm; J Boldt; S N Piper
Journal:  Anaesthesist       Date:  2009-03       Impact factor: 1.041

10.  [Ureteroscopy under intravenous analgesia with remifentanil].

Authors:  P-H Langen; M Karypiadou; J Steffens
Journal:  Urologe A       Date:  2004-06       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.